EXHIBIT 99.1

                               [LOGO]

                       N E W S   R E L E A S E


For Immediate Release

Contact:  HemaCare Corporation
          JoAnn Mannise, Director of Investor Relations
          877-310-0717
          www.hemacare.com

RELEASE DATE:  February 27, 2004

             HEMACARE CORPORATION SETS DATE FOR ITS 2004
                     ANNUAL SHAREHOLDERS MEETING


     LOS  ANGELES  ------ HemaCare Corporation (OTC  Bulletin  Board:
HEMA)  announced  today that its 2004 annual meeting of  shareholders
(the  "Meeting") will be held on Tuesday, May 25, 2004, at 9:00  a.m.
(local time) at the Company's corporate headquarters located at 21101
Oxnard  Street, Woodland Hills, California 91367.  Only  shareholders
of  record at the close of business on April 7, 2004 ("Shareholders")
will be entitled to notice of and to vote, in person or by proxy,  at
the  Meeting  or  any  adjournment or postponement  thereof.   It  is
expected  that  the proxy statement relating to the Meeting  will  be
mailed to Shareholders on or about April 10, 2004.

                     About HemaCare Corporation

     Founded  in  1978,  HemaCare  is a national  provider  of  blood
products and services and the only publicly traded company engaged in
the  blood services industry in the U.S.  HemaCare is licensed by the
FDA  and accredited by the American Association of Blood Banks.   The
Company  focuses on providing cost effective, high quality  solutions
to the blood-related needs of U.S. hospitals.

    This  press release contains "forward-looking statements" within
the  meaning of the term in the Private Securities Litigation  Reform
Act  of 1995 (Section 27A of the Securities Exchange Act of 1933,  as
amended,  and Section 21E of the Securities Exchange Act of 1934,  as
amended).  Additional written or oral forward-looking statements  may
be  made  by  the  Company  from time to time  in  filings  with  the
Securities   and   Exchange  Commission  or  otherwise.    Statements
contained  herein  that are not historical facts are  forward-looking
statements  pursuant to the safe harbor provisions referenced  above.
Forward-looking  statements  are  inherently  subject  to  risks  and
uncertainties  some of which cannot be predicted or quantified  based
on  current  expectations.   Such risks  and  uncertainties  include,
without  limitation, the risks and uncertainties set forth from  time
to  time  in  reports  filed by the Company with the  Securities  and
Exchange   Commission.   Although  the  Company  believes  that   the
expectations   reflected  in  such  forward-looking  statements   are
reasonable,  it  can  give no assurance that such  expectations  will
prove  to have been correct.  Consequently, future events and  actual
results could differ materially from those set forth in, contemplated
by,  or  underlined the forward-looking statements contained  herein.
The Company undertakes no obligation to publicly release any revision
to  these  forward  looking  statements made  to  reflect  events  or
circumstances after the date here of.

                                 ###